what this node claims
Initial digest — MTNR1A
AlphaFold v6 prediction landed for **MTNR1A** (Melatonin receptor 1A). UniProt accession: `P48039`. Lane: `sleep_circadian`. Mean per-residue pLDDT: **85.73**. _(no notes)_
vertical proof spine
evidence / risk instrument
39%
low debt pressure
29%
28%structuredebt
pLDDT pending
55%evidencethin
grade C
0%gatesdebt
0/5 gates
100%riskstrong
0 hard flags
22%exportdebt
no export
33%lineagedebt
incomplete spine
proof completeness
33% missing target, alphafold_metric, candidate, export- 01 target
- 02 fold
- 03 alphafold metric
- 04 candidate
- 05 finding
- 06 export
Metrics and receipt inputs
- confidence
- 0.6
- evidence refs
- 1
AlphaFold metrics visual
Confident backbone model
350 residues / min 31.48 / max 98.56 / source alphafold db
Very high
68.3%
239 residues / >=90
Confident
14.9%
52 residues / 70-89
Low
6.3%
22 residues / 50-69
Very low
10.6%
37 residues / <50
usable fold context with explicit model-confidence limits
Near-complete coverage / observed 350 of 350 residues.
- residues 318-350 / mean 51.52
- residues 1-21 / mean 39.9
- residues 225-228 / mean 64.66
- residues 223-223 / mean 66.19
proof debt register
29%
Visible limits, not hidden cleanup.
Peptide RX keeps unresolved proof debt attached to the public receipt. Some debts should be resolved; redaction and research-use boundaries should stay visible.